Phase 1 Dementia Alzheimer Type Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Rifaximin SSD in Dementia Trial

Dementia Alzheimer TypeDementia Associated With Cerebrovascular Disease

Jasmohan Bajaj20 enrolled1 locationNCT06718686

Recruiting

Phase 1Phase 2

Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)

Alzheimer DiseaseAlzheimer&Amp;Amp;#39;s DiseaseDementia Alzheimer Type+4 more

University of California, Los Angeles54 enrolled1 locationNCT06597942